SB

Samsara BioCapital Portfolio holdings

AUM $1.03B
1-Year Est. Return 214.94%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+214.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$59.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1 +$56.8M
2 +$15.5M
3 +$14.7M
4
AGMB
AgomAb Therapeutics NV
AGMB
+$8.5M
5
CHRS icon
Coherus Oncology
CHRS
+$6.09M

Top Sells

1 +$6.92M
2 +$2.23M
3 +$826K
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$477K
5
NUVB.WS
Nuvation Bio Inc Warrants
NUVB.WS
+$41K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRK icon
1
Scholar Rock
SRRK
$5.34B
$339M 32.95%
6,897,652
MLYS icon
2
Mineralys Therapeutics
MLYS
$2.03B
$159M 15.45%
5,871,018
ALMS
3
Alumis Inc
ALMS
$2.58B
$140M 13.58%
6,345,219
+588,235
SEPN
4
Septerna Inc
SEPN
$1.36B
$75.7M 7.35%
3,149,128
KLRS
5
Kalaris Therapeutics
KLRS
$112M
$74.7M 7.26%
12,948,081
SGP
6
SpyGlass Pharma
SGP
$619M
$54.7M 5.31%
+2,109,953
NGNE icon
7
Neurogene
NGNE
$414M
$34.6M 3.36%
1,717,127
IVA
8
Inventiva
IVA
$844M
$28.8M 2.8%
5,194,805
STRO icon
9
Sutro Biopharma
STRO
$408M
$26.5M 2.57%
1,062,872
+858,369
JBIO
10
Jade Biosciences
JBIO
$872M
$13.6M 1.32%
968,798
VTVT icon
11
vTv Therapeutics
VTVT
$131M
$11.8M 1.15%
298,496
AQST icon
12
Aquestive Therapeutics
AQST
$499M
$10.4M 1.01%
2,500,000
XFOR icon
13
X4 Pharmaceuticals
XFOR
$383M
$7.57M 0.74%
1,832,566
-127,434
NKTX icon
14
Nkarta
NKTX
$195M
$7.4M 0.72%
3,507,666
ACLX
15
DELISTED
Arcellx
ACLX
$6.99M 0.68%
60,873
UPB
16
Upstream Bio Inc
UPB
$408M
$6.62M 0.64%
736,047
ABVX
17
Abivax
ABVX
$6.61B
$6.3M 0.61%
56,581
-18,861
AGMB
18
AgomAb Therapeutics NV
AGMB
$625M
$6.29M 0.61%
+600,000
RANI icon
19
Rani Therapeutics
RANI
$96.2M
$6.25M 0.61%
8,500,000
CHRS icon
20
Coherus Oncology
CHRS
$228M
$5.79M 0.56%
+3,428,571
PVLA
21
Palvella Therapeutics
PVLA
$1.58B
$4.79M 0.47%
38,432
-66,385
GOSS icon
22
Gossamer Bio
GOSS
$44.6M
$2.37M 0.23%
7,222,559
NUVB.WS
23
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
-124,119
CTNM
24
Contineum Therapeutics
CTNM
$466M
-72,245